Abstract Body

Background

A higher incidence and more rapid progression of several types of non-AIDS-defining cancer (NADC) have been reported in people living with HIV (PLWH). However, the exact mechanism linking HIV-1 infection to the development of NADCs is not yet fully understood. In vitro studies have suggested that viral molecules carried by exosomes derived from HIV-1-infected cells can promote and exacerbate cancer. Herein, we analysed the proteomic (viral and host) profile of exosomes from patients with active NADC, stratified according to the presence or absence of HIV infection.

Methods

4 study groups were included: 15 PLWH on ART with NADC (HIV+NADC+ group), 15 people with NADC without HIV-1 (NADC+ group), 15 PLWH on cART without NADC (HIV+ group) and 15 healthy volunteers (HC group). A non-targeted label-free quantitative proteomic by LC-MS/MS, parallel reaction monitoring, and western blot analyses were performed in purified exosomes from plasma of all study subjects. 

Results

gp120, RT and IN HIV-1 proteins were detected in the exosomes of HIV+NADC+ group and HIV+ group. Interestingly, gp120 protein was increased in HIV+NADC+ group compared to HIV+ group (p<0.05), the IN protein was decreased in HIV+NADC+ group compared to HIV+ group (p<0.05) while the RT protein did not show differences between both groups. Of note both gp120 and RT proteins, have been previously associated with cancer events. Additionality, 40 human proteins were found differentially expressed (DE) in the exosomes of HIV+NADC+ group compared to NADC+ group. Remarkably, among these proteins, five pro-oncogenic (QSOX1, COMP, FTL, OIT3, KRT6B) were upregulated and three anti-oncogenic (HGFAC, GPX3, and SPARCL1) were downregulated in HIV+NADC+. Moreover, six of these eight proteins were also DE in HIV+ group compared to the NADC+ in the same direction as the HIV+NADC+ versus NADC+ groups.

Conclusions

The presence of oncogenic HIV-1 proteins and several other cancer-related proteins from the host carried by exosomes in people living with both HIV and NADCs implies that HIV infection might be a significant factor in the dysregulation of “onco-proteins” influencing a poorer prognosis in those patients with NADCs.

Table or Figure